Abstract:Background: Acute kidney injury (AKI) remains a major global public health concern due to its high morbidity and mortality. The progression from AKI to chronic kidney disease (CKD) makes it a scientific problem to be solved. However, it is with lack of effective treatments. Summary: Both innate and adaptive immune systems participate in the inflammatory process during AKI, and excessive or dysregulated immune responses play a pathogenic role in renal fibrosis, which is an important hallmark of CKD. Studies on the pathogenesis of AKI and CKD have clarified that renal injury induces the production of various chemokines by renal parenchyma cells or resident immune cells, which recruits multiple-subtype lymphocytes in circulation. Some infiltrated lymphocytes exacerbate injury by proinflammatory cytokine production, cytotoxicity, and interaction with renal resident cells, which constructs the inflammatory environment and induces further injury, even death of renal parenchyma cells. Others promote tissue repair by producing protective cytokines. In this review, we outline the diversity of these lymphocytes and their mechanisms to regulate the whole pathogenic stages of AKI and CKD; discuss the chronological responses and the plasticity of lymphocytes related to AKI and CKD progression; and introduce the potential therapies targeting lymphocytes of AKI and CKD, including the interventions of chemokines, cytokines, and lymphocyte frequency regulation in vivo , adaptive transfer of ex-expanded lymphocytes, and the treatments of gut microbiota or metabolite regulations based on gut-kidney axis. Key Message: In the process of AKI and CKD, T helper (Th) cells, innate, and innate-like lymphocytes exert mainly pathogenic roles, while double-negative T (DNT) cells and regulatory T cells (Tregs) are confirmed to be protective. Understanding the mechanisms by which lymphocytes mediate renal injury and renal fibrosis is necessary to promote the development of specific therapeutic strategies to protect from AKI and prevent the progression of CKD.

γδ T cells in immune-mediated kidney disease

Unconventional T cells and kidney disease

Glomerulonephritis: immunopathogenesis and immunotherapy

T Cell Responses in Immune-Mediated IgA Nephropathy

T Cell Infiltration is Associated with Kidney Injury in Patients with Anti-Glomerular Basement Membrane Disease.

CKD therapy to improve outcomes of immune-mediated glomerular diseases

Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond

Tissue-resident memory T cells break tolerance to renal autoantigens and orchestrate immune-mediated nephritis

Expanding role of T cells in acute kidney injury

The T cell as a bridge between innate and adaptive immune systems: Implications for the kidney

Effector and regulatory B cells in immune-mediated kidney disease

Lymphocytes: Versatile Participants in Acute Kidney Injury and Progression to Chronic Kidney Disease

Novel targets for immunotherapy in glomerulonephritis

New perspectives in treatment of glomerulonephritis

Single-Cell Analysis Provides New Insights into the Roles of Tertiary Lymphoid Structures and Immune Cell Infiltration in Kidney Injury and Chronic Kidney Disease

Th17 cells: A new target in kidney disease research

New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid

Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes

Immunology of Kidney Disease

T Lymphocytes and Acute Kidney Injury: Update